10 Participants Needed

Hands-free Exoskeleton for Spinal Cord Injury

MA
LM
BS
Overseen ByBrian Saba
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wandercraft
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment Hands-free exoskeleton for spinal cord injury?

Research shows that powered exoskeletons can help people with spinal cord injuries walk at modest speeds, and their effectiveness improves with more training sessions. Additionally, exoskeletons have been shown to improve hand function in individuals with spinal cord injuries, suggesting potential benefits for overall mobility.12345

Is the hands-free exoskeleton generally safe for humans?

The hands-free exoskeleton has been studied for safety in people with spinal cord injuries. While it can be safe and feasible, some users experienced low blood pressure, and there were rare cases of bone fractures. Extra safety measures and training are recommended to minimize risks.36789

How does the hands-free exoskeleton treatment for spinal cord injury differ from other treatments?

The hands-free exoskeleton treatment is unique because it allows individuals with spinal cord injuries to walk using a robotic device without needing to use their hands, which is different from other treatments that may require manual control or assistance. This approach can enhance mobility and independence for those with severe disabilities.310111213

Eligibility Criteria

This trial is for adults over 18 with spinal cord injury (SCI) at or above T6, who are at least 6 months post-injury. Participants must live in the US, speak English, and be able to consent. They should attend multiple training sessions with a companion who also meets similar criteria. Excluded are those with severe diseases, certain bone density issues, untreated conditions like hypertension or spasticity, pregnancy, participation in other trials, and inability to fit or operate the exoskeleton.

Inclusion Criteria

I am willing to attend 9-10 visits for training and assessments with the SCI user.
I am 18 or older and use a spinal cord injury program.
I have been living with a spinal cord injury for at least 6 months.
See 6 more

Exclusion Criteria

SCI user: Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician
SCI user: Total hip BMD T-scores < -3.5
SCI user: Untreatable severe spasticity judged to be contraindicated by the site physician
See 24 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Device Fitting and Training

Participants undergo device fitting and five training sessions to learn basic skills with the exoskeleton, concluding with a competency evaluation

2-3 weeks
6 visits (in-person)

Effectiveness Evaluation

Participants are evaluated on the effectiveness of the exoskeleton, including assessments of safety, health benefits, and satisfaction

1 week
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Hands-free exoskeleton
Trial Overview The study tests a hands-free personal exoskeleton's safety and effectiveness for individuals with SCI. It involves training sessions where participants learn to use the device under supervision to assess its impact on their mobility and daily living activities.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Hands-free exoskeletonExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wandercraft

Lead Sponsor

Trials
10
Recruited
310+

Findings from Research

A 51-year-old man with a C6 spinal cord injury showed significant improvements in hand function after 20 sessions of robot-assisted training over 10 weeks, with grip force increasing from 13.5 to 19.6 kg.
The training, which utilized myoelectric pattern recognition to assist hand movements, resulted in faster task completion and improved scores on functional tests, demonstrating the effectiveness of this rehabilitation approach for spinal cord injury patients.
Robotic Hand-Assisted Training for Spinal Cord Injury Driven by Myoelectric Pattern Recognition: A Case Report.Lu, Z., Tong, KY., Shin, H., et al.[2017]
The Berlin Bimanual Test for Tetraplegia (BeBiTT) is a reliable and valid tool for assessing bimanual hand function in individuals with cervical spinal cord injury, showing excellent interrater reliability and strong correlations with established measures of independence.
Using a brain/neural hand exoskeleton significantly improved participants' performance on the BeBiTT, indicating that this assistive technology can effectively enhance bimanual task performance in individuals with tetraplegia.
The Berlin Bimanual Test for Tetraplegia (BeBiTT): development, psychometric properties, and sensitivity to change in assistive hand exoskeleton application.Angerhöfer, C., Vermehren, M., Colucci, A., et al.[2023]
The study involving 11 participants with acute spinal cord injuries demonstrated that exoskeletal-assisted walking is safe, with no serious adverse events reported during up to 25 training sessions.
Participants showed significant improvements in walking distance and speed, indicating that this intervention is feasible and effective for enhancing mobility in individuals less than 6 months post-injury.
The Safety and Feasibility of Exoskeletal-Assisted Walking in Acute Rehabilitation After Spinal Cord Injury.McIntosh, K., Charbonneau, R., Bensaada, Y., et al.[2020]

References

Robotic Hand-Assisted Training for Spinal Cord Injury Driven by Myoelectric Pattern Recognition: A Case Report. [2017]
The Berlin Bimanual Test for Tetraplegia (BeBiTT): development, psychometric properties, and sensitivity to change in assistive hand exoskeleton application. [2023]
The Safety and Feasibility of Exoskeletal-Assisted Walking in Acute Rehabilitation After Spinal Cord Injury. [2020]
Gait speed using powered robotic exoskeletons after spinal cord injury: a systematic review and correlational study. [2018]
The Effectiveness and Safety of Exoskeletons as Assistive and Rehabilitation Devices in the Treatment of Neurologic Gait Disorders in Patients with Spinal Cord Injury: A Systematic Review. [2020]
A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations. [2023]
Safety and feasibility of exoskeleton-assisted walking during acute/sub-acute SCI in an inpatient rehabilitation facility: A single-group preliminary study. [2021]
Case Report: Description of two fractures during the use of a powered exoskeleton. [2023]
Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis. [2022]
Eyes-Free Tongue Gesture and Tongue Joystick Control of a Five DOF Upper-Limb Exoskeleton for Severely Disabled Individuals. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
A novel five degree of freedom user command controller in people with spinal cord injury and non-injured for full upper extremity neuroprostheses, wearable powered orthoses and prosthetics. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Exo-Glove Poly II: A Polymer-Based Soft Wearable Robot for the Hand with a Tendon-Driven Actuation System. [2020]
13.United Statespubmed.ncbi.nlm.nih.gov
Improving Grasp Function After Spinal Cord Injury With a Soft Robotic Glove. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security